Fair value (multi-method)
Four independent methods triangulate what WST is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$146.17
Method range
$42.44 – $343.70
median $231.00
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $146.17 | -53.52% |
| Exit multiple | $343.70 | +9.28% |
| Analyst target | $315.83 | +0.42% |
| Graham number | $42.44 | -86.50% |
- Forward DCF$146.17
- Exit multiple$343.70
- Analyst target$315.83
- Graham number$42.44
Stock price
$314.50
FCF / share (TTM)
$0.66
3Y FCF CAGR
10.5%
Fair value @ hist. growth
$14.99
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
55.0%
per year over your projection horizon
Margin of safety -1997.6% vs hist-growth DCF
Historical 3Y CAGR
10.5%
Your model implies
55.0%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at 10% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 8.5% | 50.6% | 49.6% | 48.5% | 47.3% | 46.0% |
| 9.5% | 53.7% | 52.8% | 51.8% | 50.8% | 49.7% |
| 10.5% | 56.6% | 55.8% | 55.0% | 54.1% | 53.1% |
| 11.5% | 59.4% | 58.7% | 57.9% | 57.1% | 56.2% |
| 12.5% | 62.0% | 61.4% | 60.7% | 60.0% | 59.2% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
5.95
Demanding vs growth
Net cash
$375M
Total debt − cash
Beta
1.18
Vs market benchmark
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation